Skip to content

For prescribers and pharmacists

Continuing education on opioids, pain management and addiction

    New Alaska legislation requires a minimum of two hours of continuing education in pain management, opioid use and addiction (unless you do not hold a valid DEA registration). We’ve curated list of several accredited online courses that can be used to fulfill the new CME/CNE requirement.

What can you do to keep patients safe?

    Call the UW Medicine Pain and Opioid Consult Hotline

    Thanks to a partnership between the State of Alaska and the University of Washington, UW Medicine pain pharmacists and physicians are available Monday through Friday, 7:30 AM to 3:30 PM AKT (excluding holidays) to provide clinical advice at no charge to Alaska providers. Call 1-844-520-PAIN (7246).

    Providers may receive consultations for clinicians treating patients with complex pain medication regimens, particularly high dose opioids. This can include individualized opioid taper plans; systematic management of withdrawal syndrome; evaluation/recommendation of non-opioid/adjuvant analgesic treatment; triage and risk screening; individualized case consultation for client care and medication management; and explanations of Center for Disease Control and Prevention (CDC) opioid guidelines.

    Use the PDMP every time

    Use the Alaska Prescription Drug Monitoring Program. The Alaska Prescription Drug Monitoring Program (AKPDMP) is a patient safety tool, used to make prescribing decisions based on patient’s histories. This program is designed to improve patient care and foster the goal of reducing misuse and diversion of controlled substances. AKPDMP is used to monitor Schedule II -V controlled substances dispensed in Alaska.

    Learn more about legislation related the program, tutorials on how to use it, and more, at the PDMP page sponsored by the Department of Commerce, Community and Economic Development.

    Have a discussion
      • Consider using this Alaska Acute Pain Treatment Discussion Tool to discuss the management of acute pain with your patient. Learn more about this tool and how to use it in this letter to prescribers​.
      • People of every age, gender and social status have become addicted to opioids. It’s important to talk about the risk factors with everyone.
      • When making the decision to prescribe opioids rather than using other therapy for pain, ask about previous drug use, history of substance abuse disorder or overdose, benzodiazepine use, sleep-disordered breathing, and other co-existing mental health conditions such as depression, anxiety and PTSI.
      • Always focus on functional goals and improvement, and set the criteria for stopping or continuing use. Talk to patients about how opioid therapy will be discontinued if its benefits do not outweigh the risks.
      • Go low dose by using the lowest dosage on the product’s labeling. Match the duration of use with the next scheduled reassessment.
      • Educate your patient about safe use, storage and proper disposal of opioids.
    Monitor and reassess

    Set an initial reassessment within one to four weeks, and monitor the patient for signs of misuse of opioids at every assessment.

      • Only continue opioid treatment after confirming clinically meaningful improvements
      • Evaluate risk of harm or misuse
      • If risk is elevated, taper dose
      • Seek opioid misuse treatment for the patient as needed

    Resource from the Substance Abuse and Mental Health Services Administration can provide advice on treatment options:

    Prescribe naloxone

    Learn how co-prescribing naloxone can help prevent overdose. Naloxone is also available through Project Hope.

    Help patients who are dependent and/or addicted

    The Division of Behavioral Health maintains a page about treatment options in Alaska.

    The Substance Abuse and Mental Health Services Administration’s MAT webpage offers more information on medication-assisted treatment, like this Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide.

    Learn about how to assist a patient with the Voluntary Nonopioid Directive

    The Voluntary Nonopioid Directive (VNOD) is a form for individuals who wish to decline future treatment with opioids. Health care providers and patients complete and sign this form together. The VNOD aims to prevent providers from inadvertently offering certain controlled substances to those who could be adversely affected. It also empowers patients to proactively inform their provider that they do not wish to receive opioids for any reason. Access the Voluntary Nonopioid Directive and additional guidance here.

More resources available to providers

    Alaska Responder Relief Line

    The COVID-19 pandemic has put additional strain on Alaska’s health care workforce, EMTs, doctors, nurses, health aids, social workers, CNAs and others working on the front lines of the COVID-19 crisis. In May, a new support line became available for anyone who’s at risk of exposure to COVID-19 as a result of their job in a medical setting. Learn more about the Alaska Responder Relief Line.